• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性乙型肝炎患者肝脏生化指标与肝硬度的相关性及肝纤维化预测模型的建立

Correlation of liver biochemistry with liver stiffness in chronic hepatitis B and development of a predictive model for liver fibrosis.

作者信息

Fung James, Lai Ching-Lung, Fong Daniel Yee-Tak, Yuen John Chi-Hang, Wong Danny Ka-Ho, Yuen Man-Fung

机构信息

Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong SAR, Hong Kong.

出版信息

Liver Int. 2008 Dec;28(10):1408-16. doi: 10.1111/j.1478-3231.2008.01784.x. Epub 2008 May 14.

DOI:10.1111/j.1478-3231.2008.01784.x
PMID:18482268
Abstract

UNLABELLED

Abstract Aim: To correlate liver stiffness with demographical factors and routine liver biochemistry and to assess the predictive value of these as potential markers of fibrosis.

METHODS

Transient elastography was performed in 1268 chronic hepatitis B (CHB) patients. According to a previous validated study for CHB, liver stiffness of >8.1 and >10.3 kPa were used as cut-off values for defining severe fibrosis and cirrhosis respectively.

RESULTS

Liver stiffness correlated positively with bilirubin, alkaline phosphatase (ALP), gamma-glutamyl transpeptidase (GGT), aspartate aminotransferase (AST), alanine aminotransferase (ALT), globulin, alpha-fetoprotein (AFP) and HBV DNA levels and negatively with albumin and platelet levels (P<0.05 for all correlations). From 13 parameters (age, sex, platelet, AST, ALT, GGT, AFP, albumin, globulin, bilirubin, ALP, HBV DNA and hepatitis B e-antigen), four best parameters (AST, platelet, GGT and AFP) were used to derive a liver stiffness model. Using log (index)=1.44+0.1490(GGT)+0.3308 log (AST)-0.5846 log (platelets)+0.1148 log (AFP+1) to predict both severe fibrosis and cirrhosis had area under the receiver operating characteristics curve of 0.85.

CONCLUSION

Routine liver biochemistry correlated well with liver stiffness in Asian CHB patients. A model using simple serum markers can predict liver stiffness, and further studies are required to validate the usefulness of these simple tests as non-invasive markers of fibrosis in CHB.

摘要

未标注

摘要 目的:将肝脏硬度与人口统计学因素及常规肝脏生化指标进行关联,并评估这些指标作为纤维化潜在标志物的预测价值。

方法

对1268例慢性乙型肝炎(CHB)患者进行瞬时弹性成像检查。根据先前一项针对CHB的有效研究,将肝脏硬度>8.1 kPa和>10.3 kPa分别用作定义严重纤维化和肝硬化的临界值。

结果

肝脏硬度与胆红素、碱性磷酸酶(ALP)、γ-谷氨酰转肽酶(GGT)、天冬氨酸氨基转移酶(AST)、丙氨酸氨基转移酶(ALT)、球蛋白、甲胎蛋白(AFP)和HBV DNA水平呈正相关,与白蛋白和血小板水平呈负相关(所有相关性P<0.05)。从13项参数(年龄、性别、血小板、AST、ALT、GGT、AFP、白蛋白、球蛋白、胆红素、ALP、HBV DNA和乙肝e抗原)中,选取四个最佳参数(AST、血小板、GGT和AFP)来建立肝脏硬度模型。使用log(指数)=1.44 + 0.1490(GGT)+ 0.3308 log(AST)- 0.5846 log(血小板)+ 0.1148 log(AFP + 1)来预测严重纤维化和肝硬化,受试者工作特征曲线下面积为0.85。

结论

在亚洲CHB患者中,常规肝脏生化指标与肝脏硬度密切相关。使用简单血清标志物的模型可预测肝脏硬度,需要进一步研究来验证这些简单检测作为CHB纤维化非侵入性标志物的实用性。

相似文献

1
Correlation of liver biochemistry with liver stiffness in chronic hepatitis B and development of a predictive model for liver fibrosis.慢性乙型肝炎患者肝脏生化指标与肝硬度的相关性及肝纤维化预测模型的建立
Liver Int. 2008 Dec;28(10):1408-16. doi: 10.1111/j.1478-3231.2008.01784.x. Epub 2008 May 14.
2
The diagnostic value of non-invasive tests for the evaluation of liver fibrosis in chronic hepatitis B patients.非侵入性检测对慢性乙型肝炎患者肝纤维化评估的诊断价值。
Scand J Clin Lab Invest. 2013;73(4):300-8. doi: 10.3109/00365513.2013.773592. Epub 2013 Mar 20.
3
[Value of non-invasive models of liver fibrosis in judgment of treatment timing in chronic hepatitis B patients with ALT < 2×upper limit of normal].[无创肝纤维化模型在判断ALT<2倍正常上限的慢性乙型肝炎患者治疗时机中的价值]
Zhonghua Gan Zang Bing Za Zhi. 2016 Sep 20;24(9):665-670. doi: 10.3760/cma.j.issn.1007-3418.2016.09.006.
4
Is there any non-invasive marker replace the needle liver biopsy predictive for liver fibrosis, in patients with chronic hepatitis?对于慢性肝炎患者,是否存在任何非侵入性标志物可替代肝穿刺活检来预测肝纤维化?
Hepatogastroenterology. 2009 Sep-Oct;56(94-95):1459-65.
5
Fibro-α score as a simple and useful non-invasive test for predicting significant liver fibrosis in chronic hepatitis C patients.Fibro-α评分作为一种简单且有用的非侵入性检测方法,用于预测慢性丙型肝炎患者的显著肝纤维化。
Arab J Gastroenterol. 2011 Jun;12(2):74-9. doi: 10.1016/j.ajg.2011.04.006. Epub 2011 May 17.
6
Performance of several simple, noninvasive models for assessing significant liver fibrosis in patients with chronic hepatitis B.几种用于评估慢性乙型肝炎患者显著肝纤维化的简单非侵入性模型的性能
Croat Med J. 2015 Jun;56(3):272-9. doi: 10.3325/cmj.2015.56.272.
7
[Study on the influence factors of the serum fibrosis markers].[血清纤维化标志物的影响因素研究]
Zhonghua Gan Zang Bing Za Zhi. 2003 Jan;11(1):23-5.
8
Diagnostic accuracy of transient elastography (FibroScan) versus the aspartate transaminase to platelet ratio index in assessing liver fibrosis in chronic hepatitis B: the role in primary care setting.瞬时弹性成像(FibroScan)与天门冬氨酸氨基转移酶血小板比值指数在慢性乙型肝炎肝纤维化评估中的诊断准确性:在基层医疗环境中的作用。
J Clin Pathol. 2011 Oct;64(10):916-20. doi: 10.1136/jclinpath-2011-200044. Epub 2011 Jun 13.
9
Diagnostic value of gamma-glutamyl transpeptidase to alkaline phosphatase ratio combined with gamma-glutamyl transpeptidase to aspartate aminotransferase ratio and alanine aminotransferase to aspartate aminotransferase ratio in alpha-fetoprotein-negative hepatocellular carcinoma.γ-谷氨酰转肽酶与碱性磷酸酶比值、γ-谷氨酰转肽酶与天冬氨酸氨基转移酶比值和丙氨酸氨基转移酶与天冬氨酸氨基转移酶比值联合对甲胎蛋白阴性肝细胞癌的诊断价值。
Cancer Med. 2021 Jul;10(14):4844-4854. doi: 10.1002/cam4.4057. Epub 2021 Jun 18.
10
Clinical usefulness of mean platelet volume and red blood cell distribution width to platelet ratio for predicting the severity of hepatic fibrosis in chronic hepatitis B virus patients.平均血小板体积和红细胞分布宽度与血小板比值对预测慢性乙型肝炎病毒患者肝纤维化严重程度的临床实用性。
Eur J Gastroenterol Hepatol. 2014 Dec;26(12):1320-4. doi: 10.1097/MEG.0000000000000203.

引用本文的文献

1
Hepatitis B virus genotypes and antiviral drug resistance mutations in treatment-naïve patients with chronic hepatitis B in Bacninh, Vietnam: a cross-sectional study.越南北宁初治慢性乙型肝炎患者的乙型肝炎病毒基因型及抗病毒药物耐药突变:一项横断面研究
Ther Adv Infect Dis. 2025 Jun 14;12:20499361251344784. doi: 10.1177/20499361251344784. eCollection 2025 Jan-Dec.
2
Noninvasive Models to Assess Liver Inflammation and Fibrosis in Chronic HBV Infected Patients with Normal or Mildly Elevated Alanine Transaminase Levels: Which One Is Most Suitable?评估丙氨酸转氨酶水平正常或轻度升高的慢性HBV感染患者肝脏炎症和纤维化的非侵入性模型:哪一种最合适?
Diagnostics (Basel). 2024 Feb 20;14(5):456. doi: 10.3390/diagnostics14050456.
3
High prevalence of de novo metabolic dysfunction-associated fatty liver disease after liver transplantation and the role of controlled attenuation parameter.
肝移植后新发代谢相关脂肪性肝病的高患病率及受控衰减参数的作用。
BMC Gastroenterol. 2023 Sep 12;23(1):307. doi: 10.1186/s12876-023-02940-y.
4
Effectiveness of antiviral treatment in HBeAg-negative chronic hepatitis B patients with normal or mildly elevated alanine aminotransferase: a retrospective study.抗病毒治疗对 HBeAg 阴性慢性乙型肝炎患者中丙氨酸氨基转移酶正常或轻度升高的疗效:一项回顾性研究。
BMC Gastroenterol. 2022 Aug 17;22(1):387. doi: 10.1186/s12876-022-02471-y.
5
Effect of Candesartan and Ramipril on Liver Fibrosis in Patients with Chronic Hepatitis C Viral Infection: A Randomized Controlled Prospective Study.坎地沙坦和雷米普利对慢性丙型肝炎病毒感染患者肝纤维化的影响:一项随机对照前瞻性研究。
Curr Ther Res Clin Exp. 2021 Nov 12;95:100654. doi: 10.1016/j.curtheres.2021.100654. eCollection 2021.
6
Performance of noninvasive tools for identification of minimal liver fibrosis in patients with hepatitis B virus infection.用于乙型肝炎病毒感染者中无症状性肝纤维化的无创性工具的性能。
J Clin Lab Anal. 2021 Sep;35(9):e23960. doi: 10.1002/jcla.23960. Epub 2021 Aug 17.
7
Prognostic significance of preoperative systemic inflammatory biomarkers in patients with hepatocellular carcinoma after microwave ablation and establishment of a nomogram.术前全身炎症生物标志物对微波消融治疗后肝细胞癌患者的预后意义及列线图的建立。
Sci Rep. 2021 Jul 5;11(1):13814. doi: 10.1038/s41598-021-93289-3.
8
Relationship between platelet-based models and the prognosis of patients with malignant hepatic tumors.基于血小板的模型与恶性肝肿瘤患者预后的关系。
Oncol Lett. 2020 Mar;19(3):2384-2396. doi: 10.3892/ol.2020.11317. Epub 2020 Jan 17.
9
Comparison of the prognostic value of platelet-based prognostic models in patients with malignant hepatic tumors after TACE therapy.经动脉化疗栓塞(TACE)治疗后血小板相关预后模型对恶性肝肿瘤患者预后价值的比较
Acta Cir Bras. 2019 Sep 16;34(7):e201900710. doi: 10.1590/s0102-865020190070000010.
10
Genotyping of HBV and tracking of resistance mutations in treatment-naïve patients with chronic hepatitis B.初治慢性乙型肝炎患者的HBV基因分型及耐药突变监测
Infect Drug Resist. 2017 Jul 5;10:201-207. doi: 10.2147/IDR.S135420. eCollection 2017.